SEATTLE & CAMBRIDGE, Mass. & TOKYO, September 23, 2026--(BUSINESS WIRE)--Aurion Biotech, Inc. ("Aurion Biotech"), a commercial-stage regenerative cell therapy company dedicated to restoring vision and ...
Eyecare giant Alcon has bought a majority stake in cell therapy start-up Aurion Biotech, replacing the company's chief executive, in the culmination of a months-long struggle for control. In a ...
Philippine Aurion Solar Technologies Inc. is investing more than PHP 3.34 billion to build a 1.3-hectare solar cell manufacturing facility at First Philippine Industrial Park (FPIP) in Sto. Tomas, ...
Leverages Alcon's global scale with Aurion's cell therapy expertise to accelerate US Phase 3 development in fall of 2025 Alcon, the global leader in eye care, has acquired a majority interest in ...
TecDax 4.015 10:53:45 0,93% 10:53:45 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results